Scotland endorses five new therapies for NHS use
Five new medicines are to be funded by the NHS in Scotland, bringing new treatment options for cancer, multiple sclerosis and rheumatoid arthritis, as well as a new contraceptive.
Read More
Tag: Kyleena
UK launch for Bayer’s five-year contraceptive Kyleena
A new long-acting reversible contraception method offering protection from unplanned pregnancy for up to five years has been launched in the UK.
Read More
Bayer bags EU nod for 5yr contraceptive
Bayer has been given a green light in the EU for its low-dose levonorgestrel-releasing intrauterine system as a means to prevent pregnancy.
Read More
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
